Jennifer Lyn Herron - 09 Sep 2021 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
Director
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Jennifer Herron
Issuer symbol
N/A
Transactions as of
09 Sep 2021
Net transactions value
$0
Form type
4
Filing time
28 Sep 2021, 16:02:27 UTC
Previous filing
28 Sep 2021
Next filing
30 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNCA Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Sep 2021 Common Stock 30,000 $2.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date.